Cardinal Health, Inc.

New York Stock Exchange
Back to all articles
Slightly Bearish -10

Is Cardinal Health (CAH) Stock Above Fair Value Or About Right? - simplywall.st

AI-generated analysis

📈 Cardinal Health stock has delivered very strong gains, rising 420.2% over the past five years.

💰 The company trades at a P/E ratio of 33.7x, which is higher than both the Healthcare industry average (25.3x) and peer group average (27.8x).

📊 Simply Wall St valuation checks score Cardinal Health a 2 out of 6, indicating the stock leans expensive rather than being a clear bargain.

⚖️ The model implies a fair P/E ratio of 32.8x, suggesting the current market price roughly matches expectations for the company's size and risk profile.

🛑 Investors face a key question regarding whether Cardinal Health can sustain its earnings power without running into margin or working capital pressure.

📉 The stock does not screen as a clear bargain on earnings multiples, though it is not considered extreme relative to tailored benchmarks.

Bullish Signals
  • Cardinal Health has delivered very strong gains over the past five years, with shares up 420.2%, indicating robust long-term performance.
  • The company operates as a healthcare services and products provider in the United States and internationally, maintaining a significant market presence.
Risk Factors
  • Cardinal Health trades at a P/E ratio of 33.7x, which is substantially higher than the Healthcare industry average of 25.3x and peer group average of 27.8x.
  • Valuation checks score the stock 2 out of 6, suggesting it leans expensive rather than being a clear bargain for investors.
  • The current valuation implies that market expectations have already priced in solid execution, leaving limited margin for error regarding operating performance.
Full Analysis
Cardinal Health (CAH) shares have surged 420.2% over the past five years, leading Simply Wall St to conclude that the stock is no longer obviously cheap on a broad valuation view. The company currently scores 2 out of 6 on wider valuation checks, indicating it leans expensive rather than representing a clear bargain for investors seeking undervalued opportunities. The article analyzes Cardinal Health's earnings power using the P/E ratio, noting that CAH trades at 33.7x earnings. This multiple is significantly higher than the broader Healthcare industry average of 25.3x and the peer group average of 27.8x. While a model implies a fair P/E of 32.8x, suggesting the current price roughly matches expectations based on size and risk, the stock does not screen as a clear bargain. The core investment debate for Cardinal Health centers on whether its strong share price run leaves sufficient potential reward relative to its current valuation. The market appears to have priced in solid execution and stable profitability, meaning future performance must sustain this richer multiple without facing pressure from operating margins or working capital needs.